Generic medicine

Streptokinase 1500000 IU Injection

Reviewed educational reference: what Streptokinase is used for, how it works, its side effects and safety advice, plus the Indian brands that contain it.

Reviewed by Sohan Lal Kushwaha
Molecule
Streptokinase
Strength
1500000 IU
Dosage form
Injection
Drug class
Thrombolytic agent

Related products

No reviewed products are currently published for this generic.

Streptokinase 1500000 IU Injection contains Streptokinase, a potent thrombolytic agent derived from group C beta-hemolytic streptococci. It is a protein that acts as an enzyme activator to dissolve blood clots within the vascular system. By converting plasminogen to plasmin, it facilitates the breakdown of fibrin clots, which is essential in managing acute myocardial infarction and other thromboembolic conditions. This medication is administered exclusively in a hospital setting by trained medical professionals due to its high risk of bleeding complications and the potential for severe allergic reactions.

At a glance

Quick look

Streptokinase 1500000 IU Injection is a potent thrombolytic agent containing Streptokinase.

How it works

It works by converting plasminogen to plasmin to dissolve blood clots.

Who it is for

It is used to treat life-threatening conditions caused by arterial or venous thrombosis.

Uses it for
Myocardial infarctionPulmonary embolismDeep vein thrombosisArterial occlusionCatheter clearanceThromboembolism

Uses of Streptokinase

  • Acute myocardial infarction (heart attack)
  • Deep vein thrombosis (DVT)
  • Pulmonary embolism
  • Arterial thrombosis or embolism
  • Occluded central venous catheters
  • Chronic peripheral arterial occlusions

Benefits of Streptokinase

Rapid Clot Dissolution
The primary benefit of Streptokinase 1500000 IU Injection is its ability to rapidly restore blood flow in blocked vessels. In the context of an acute myocardial infarction, timely administration can significantly reduce the size of the infarct, preserve myocardial function, and improve overall survival rates by clearing the coronary artery obstruction.

Systemic Fibrinolysis
Unlike mechanical interventions, Streptokinase 1500000 IU Injection provides a systemic approach to thrombolysis. It is particularly effective in cases where surgical intervention is not immediately feasible or when multiple small clots are present in the vascular tree. By activating the body's natural fibrinolytic system, it helps in dissolving clots that might otherwise be inaccessible to surgical tools.

Side effects of Streptokinase

The most common side effect associated with Streptokinase 1500000 IU Injection is bleeding, which can range from minor bruising at the injection site to life-threatening internal hemorrhage. Because Streptokinase is a bacterial protein, the immune system may recognize it as a foreign substance, leading to allergic reactions. These reactions can manifest as fever, chills, urticaria, or in severe cases, anaphylaxis. Hypotension is also frequently observed during the infusion, often requiring a temporary reduction in the rate of administration. Other reported effects include nausea, vomiting, and musculoskeletal pain. Patients must be monitored continuously for signs of intracranial hemorrhage, which is a rare but catastrophic complication of thrombolytic therapy.

Side effectHow commonHow severeWhat to do
HemorrhageCommonSevereStop infusion and apply pressure.
HypotensionCommonModerateSlow down the infusion rate.
Allergic reactionUncommonSevereAdminister antihistamines or corticosteroids.

How to manage side effects

Hemorrhage

  • 1. Stop infusion.
  • 2. Assess site of bleeding.
  • 3. Administer blood products if needed.

Hypotension

  • 1. Reduce infusion speed.
  • 2. Monitor blood pressure.
  • 3. Administer IV fluids if necessary.

Allergic reaction

  • 1. Stop infusion.
  • 2. Administer epinephrine if anaphylaxis occurs.
  • 3. Provide respiratory support.

How to use Streptokinase

  • Streptokinase 1500000 IU Injection is administered only by qualified healthcare professionals in a clinical environment.
  • The medication is prepared by reconstituting the powder with sterile saline or water for injection.
  • It is typically administered as a slow intravenous infusion over a period determined by the clinical indication.
  • Continuous monitoring of blood pressure, heart rate, and ECG is mandatory during and after the infusion.
  • The patient must remain under observation for several hours following the completion of the dose to monitor for delayed allergic reactions or bleeding.

Special population advice

Kidney impairment

  • Monitor renal function closely.
  • Adjust dose if necessary based on clinical response.

Liver impairment

  • Use with extreme caution.
  • Monitor coagulation profile frequently.

Children

  • Use only if clearly indicated.
  • Dosing must be calculated by a specialist.

Elderly

  • Increased risk of bleeding.
  • Use lower infusion rates if tolerated.

How Streptokinase works

Streptokinase works by forming a complex with plasminogen. This complex then converts inactive plasminogen into active plasmin. Plasmin is a proteolytic enzyme that degrades fibrin, the protein scaffold that holds blood clots together. By breaking down fibrin, Streptokinase 1500000 IU Injection effectively dissolves the clot and restores blood flow to the affected tissue.

What if you miss or exceed a dose?

If you miss a dose

As Streptokinase 1500000 IU Injection is administered as a single-course emergency treatment in a hospital setting, the concept of a missed dose does not apply. The medical team will ensure the full therapeutic dose is delivered according to the established protocol for the specific condition being treated.

In case of overdose

An overdose of Streptokinase 1500000 IU Injection will result in profound systemic fibrinolysis and a high risk of severe, uncontrollable bleeding. There is no specific antidote to reverse the effects of Streptokinase immediately. In the event of an overdose, the infusion must be stopped instantly. Management involves supportive care, including the administration of blood products such as fresh frozen plasma, cryoprecipitate, or antifibrinolytic agents like tranexamic acid if bleeding is life-threatening.

AntidoteNo specific antidote

Management is supportive and focuses on stopping the bleeding.

Immediate action
Stop the infusion of Streptokinase 1500000 IU Injection immediately.
Supportive care
Apply pressure to bleeding sites and maintain hemodynamic stability.
Blood products
Administer fresh frozen plasma or cryoprecipitate to replace clotting factors.
Antifibrinolytics
Consider tranexamic acid or aminocaproic acid if bleeding is life-threatening.

Safety and precautions

When to avoid Streptokinase

Do not take if you
  • Active internal bleeding

    The drug will exacerbate hemorrhage.

  • History of hemorrhagic stroke

    High risk of recurrence of intracranial bleeding.

Use with caution
  • Recent surgery

    Increased risk of bleeding at surgical sites.

  • Uncontrolled hypertension

    Risk of intracranial hemorrhage.

  • Recent trauma

    Potential for internal bleeding.

  • Pregnancy

    Risk of placental abruption or hemorrhage.

Safety at a glance

AlcoholUse with caution

Alcohol may increase the risk of bleeding or mask symptoms of neurological complications.

PregnancyConsult your doctor

Use only if the potential benefit justifies the risk to the fetus; consult a specialist.

BreastfeedingConsult your doctor

Discuss with your doctor; the safety of this drug during lactation is not well established.

DrivingUse with caution

Do not drive or operate machinery immediately after treatment due to potential dizziness or fatigue.

KidneyUse with caution

Use with caution in patients with renal impairment; monitor closely for bleeding.

LiverUse with caution

Use with caution in patients with hepatic disease; monitor coagulation parameters.

AllergyUnsafe

Do not use if you have a known hypersensitivity to streptokinase or streptococcal proteins.

ChildrenConsult your doctor

Safety and efficacy in children have not been established; use only under expert supervision.

ElderlyUse with caution

Elderly patients are at higher risk of bleeding; monitor closely during and after infusion.

Interactions

With other medicines

Heparin

Major

Changes the medicine’s effect

What can happen: Increased risk of severe bleeding.

What to do: Monitor coagulation parameters closely and adjust doses.

Aspirin

Moderate

Changes the medicine’s effect

What can happen: Enhanced antiplatelet effect.

What to do: Use with caution and monitor for signs of bleeding.

Warfarin

Major

Changes the medicine’s effect

What can happen: Synergistic anticoagulant effect.

What to do: Avoid concurrent use unless strictly necessary.

With food and drink

  • None significantMinor

    No specific food interactions are documented for this injectable medication.

  • Herbal supplements with blood-thinning propertiesModerate

    Supplements like garlic, ginger, and ginkgo biloba may increase the risk of bleeding when combined with thrombolytic therapy.

If you have another condition

  • Bleeding disorders

    Contraindicated due to high risk of uncontrollable hemorrhage.

  • Severe hypertension

    Increases risk of intracranial hemorrhage during treatment.

Effect on laboratory tests

  • Thrombin time

    Prolonged reading

    Expected effect of fibrinolytic therapy; does not indicate a lab error.

  • Fibrinogen levels

    Decreased levels

    Reflects the systemic fibrinolytic activity of the drug.

Quick tips

  • Ensure your medical team is aware of any recent surgeries, injuries, or bleeding disorders before treatment.
  • Report any sudden headache, confusion, or weakness immediately, as these may be signs of intracranial bleeding.
  • Expect frequent blood tests to monitor your coagulation profile during and after the treatment.
  • Avoid any unnecessary physical activity or procedures that could cause injury while the drug is active in your system.
  • Inform the staff if you have ever received Streptokinase in the past, as prior exposure increases the risk of an allergic reaction.
  • Keep your healthcare provider updated on all other medications you are currently taking, especially blood thinners.

Counselling points

  • Bleeding riskImportant

    Report any unusual bleeding, bruising, or severe headache immediately.

  • Hospital stayImportant

    You will be monitored closely in the hospital for at least 24 hours.

  • Allergic reactionImportant

    Tell the staff if you feel itchy, have trouble breathing, or develop a rash.

  • ActivityGood to know

    Avoid strenuous activity or contact sports for several days after treatment.

Monitoring during treatment

Before starting

  • Complete blood count
  • Coagulation profile (PT, PTT, INR)
  • Fibrinogen levels
  • Blood pressure

During treatment

  • every hour: Monitor blood pressure and heart rate during infusion.
  • post infusion: Check coagulation profile 4 to 6 hours after completion.

What is being watched

  • Fibrinogen
  • PT/PTT
  • Hemoglobin
  • Hematocrit
  • Blood pressure

Pharmacokinetics

Absorption
Rapidly absorbed into the systemic circulation following IV administration.
Bioavailability
100% via intravenous route.
Protein binding
Not applicable as it is an enzyme activator.
Volume of distribution
Primarily confined to the vascular compartment.
Half-life
Approximately 20 to 80 minutes for the active complex.
Metabolism
Metabolized by the liver and cleared by the reticuloendothelial system.
Excretion
Excreted via the kidneys as inactive metabolites.
Onset / duration
Onset is immediate; effects persist for several hours.

Fact box

Chemical class
Bacterial protein
Habit forming
No
Therapeutic class
Fibrinolytic
Action class
Plasminogen activator
Storage
Store the unopened vials in a refrigerator at 2°C to 8°C. Protect from light. Do not freeze. Once reconstituted, use immediately.
ATC code
B01AD01
Pregnancy category
C

More information

Clinical Selection of Thrombolytics

Clinicians choose Streptokinase primarily for its cost-effectiveness and proven track record in resource-limited settings. While newer, fibrin-specific agents like alteplase offer theoretical advantages in clot selectivity, Streptokinase remains a standard of care in many regions for acute myocardial infarction. The decision to use this agent is based on the time window of the infarction, the patient's bleeding risk profile, and the availability of alternative mechanical reperfusion strategies like primary percutaneous coronary intervention. In scenarios where immediate catheterization is unavailable, Streptokinase provides a life-saving intervention that can significantly reduce mortality.

Comparison with Alternatives

When comparing Streptokinase to newer thrombolytics, the primary difference lies in its lack of fibrin specificity. This means it activates plasminogen systemically, which leads to a more pronounced reduction in circulating fibrinogen and a higher risk of systemic bleeding compared to tissue plasminogen activators. However, the clinical outcomes in terms of vessel patency are comparable when administered within the optimal therapeutic window. The choice often comes down to institutional protocols, cost considerations, and the patient's history of streptococcal exposure, which can lead to neutralizing antibodies that reduce the drug's efficacy.

Lifestyle and Treatment Expectations

Patients receiving Streptokinase 1500000 IU Injection should expect a period of intensive monitoring. During the infusion, you will be connected to an ECG monitor and have your blood pressure checked frequently. After the infusion, you will be placed on bed rest to minimize the risk of injury and bleeding. It is common to feel tired or experience mild discomfort during the recovery phase. Following discharge, your doctor will likely prescribe antiplatelet therapy, such as aspirin or clopidogrel, to prevent future clots. Adopting a heart-healthy diet, quitting smoking, and managing blood pressure are essential long-term strategies to maintain the benefits of the treatment.

Common Misconceptions

A common misconception is that Streptokinase 1500000 IU Injection is a permanent cure for heart disease. It is a temporary measure designed to clear an acute blockage. It does not treat the underlying atherosclerosis that caused the clot to form in the first place. Another myth is that it is safe for everyone. Because it is a potent blood-dissolving agent, it carries significant risks that make it unsuitable for patients with recent surgery, uncontrolled high blood pressure, or a history of bleeding disorders. Understanding that this is an emergency intervention rather than a maintenance medication is crucial for patients and their families.

References

  1. Health Products Regulatory Authority. Streptokinase 1500000 IU Injection, Summary of Product Characteristics.View sourceAccessed
  2. Drugs.com. Streptokinase Dosage Guide.View sourceAccessed
  3. Karma Laboratories. Streptokinase 1500000 IU Injection, Summary of Product Characteristics.View sourceAccessed
  4. Incepta Pharmaceuticals. Streptokinase Injection, Product Information.View sourceAccessed
  5. Goodman & Gilman's: The Pharmacological Basis of Therapeutics. 13th ed. McGraw-Hill Education.Accessed

Frequently asked questions about Streptokinase

What is the primary use of Streptokinase 1500000 IU Injection?

It is used to dissolve blood clots in conditions like heart attacks, pulmonary embolisms, and deep vein thrombosis.

Can I take Streptokinase 1500000 IU Injection at home?

No, this medication must be administered in a hospital by trained medical staff due to the risk of severe side effects.

How long does the effect of Streptokinase 1500000 IU Injection last?

The fibrinolytic effect typically lasts for several hours, but the risk of bleeding may persist for up to 24 hours.

Is Streptokinase 1500000 IU Injection the same as a blood thinner?

While it affects clotting, it is a thrombolytic, meaning it actively dissolves existing clots, unlike anticoagulants that only prevent new ones.

What should I do if I experience bleeding?

Inform the medical staff immediately; they are equipped to manage bleeding complications.

Latest